Point72 Asset Management, L.P.
Position in LRMR — Larimar Therapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in LRMR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,713,232
-$853,284 QoQ
Shares Held
1,047,385
-28.3% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,450,612 across 188 Biotechnology names. LRMR ranks #82 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in LRMR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,713,232 | 1,047,385 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,566,516 | 1,461,028 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,953,087 | 1,223,866 | Shares | Defined | 2025-11-14 | |
| 2024-09-30 | $1,356,505 | 207,100 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,375,962 | 603,581 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $3,327,456 | 438,400 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,049,320 | 450,400 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,797,250 | 455,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,626,070 | 839,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,061,150 | 455,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,961,750 | 475,000 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $1,520,000 | 475,000 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $2,124,507 | 196,896 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,270,210 | 196,896 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $973,751 | 99,160 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $252,168 | 17,260 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $369,536 | 17,260 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $261,834 | 17,260 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $221,791 | 17,260 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||